Bristol-Myers Squibb
BMY
BMY
1,728 hedge funds and large institutions have $74.8B invested in Bristol-Myers Squibb in 2018 Q3 according to their latest regulatory filings, with 107 funds opening new positions, 576 increasing their positions, 744 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
7% more call options, than puts
Call options by funds: $1.32B | Put options by funds: $1.24B
0.55% more ownership
Funds ownership: 73.32% → 73.88% (+0.55%)
23% less repeat investments, than reductions
Existing positions increased: 576 | Existing positions reduced: 744
Holders
1,728
Holding in Top 10
42
Calls
$1.32B
Puts
$1.24B
Top Buyers
| 1 | +$379M | |
| 2 | +$253M | |
| 3 | +$190M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$180M |
| 5 |
BlackRock
New York
|
+$165M |
Top Sellers
| 1 | -$397M | |
| 2 | -$214M | |
| 3 | -$213M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$201M |
| 5 |
JP Morgan Chase
New York
|
-$193M |